Acute pulmonary embolism treated with thrombolytic agents: current status of tPA and future implications for emergency medicine (Q39607069)

13 September 2017

1 reference

title

Acute pulmonary embolism treated with thrombolytic agents: current status of tPA and future implications for emergency medicine (English)

1 reference

13 September 2017

1 reference

Kessler CM

1

1 reference

13 September 2017

Druy E

series ordinal

2

1 reference

13 September 2017

Goldhaber SZ

series ordinal

3

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 November 1988

1 reference

Annals of Emergency Medicine

13 September 2017

published in

1 reference

13 September 2017

volume

17

1 reference

13 September 2017

issue

11

1 reference

13 September 2017

page(s)

1216-1220

1 reference

Pulmonary embolism and thrombophlebitis in the United States, 1970-1985

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2888%2980073-8

7 January 2021

Butyl nitrite in the induction of Kaposi's sarcoma in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2888%2980073-8

7 January 2021

Epidemiology and pathogenesis of venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2888%2980073-8

7 January 2021

Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2888%2980073-8

7 January 2021

Factors associated with correct antemortem diagnosis of major pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2888%2980073-8

7 January 2021

Natural history of pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2888%2980073-8

7 January 2021

Hemodynamic and ventricular responses to pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2888%2980073-8

7 January 2021

Pulmonary embolectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2888%2980073-8

7 January 2021

Pulmonary embolectomy. Results in ten patients

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2888%2980073-8

7 January 2021

Community-Wide Availability of Pulmonary Embolectomy with Cardiopulmonary Bypass

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2888%2980073-8

7 January 2021

Pulmonary embolectomy for acute massive pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2888%2980073-8

7 January 2021

Effect of thrombolytic therapy on pulmonary-capillary blood volume in patients with pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2888%2980073-8

7 January 2021

Thrombolysis with human extrinsic (tissue-type) plasminogen activator in dogs with femoral vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2888%2980073-8

7 January 2021

Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2888%2980073-8

7 January 2021

A comparison of the thrombolytic and hemorrhagic effects of tissue-type plasminogen activator and streptokinase in rabbits.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2888%2980073-8

7 January 2021

Thrombolysis by human tissue plasminogen activator and urokinase in rabbits with experimental pulmonary embolus

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2888%2980073-8

7 January 2021

Specific lysis of an iliofemoral thrombus by administration of extrinsic (tissue-type) plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2888%2980073-8

7 January 2021

Thrombolytic treatment with recombinant tissue-type plasminogen activator in a patient with massive pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2888%2980073-8

7 January 2021

Acute pulmonary embolism treated with tissue plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2888%2980073-8

7 January 2021

Perspectives on treatment of acute pulmonary embolism with tissue plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2888%2980073-8

7 January 2021

Recombinant tissue plasminogen activator in patients with pulmonary embolism: correlation of fibrinolytic specificity and efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2888%2980073-8

7 January 2021

Early reversal of right ventricular dysfunction in patients with acute pulmonary embolism after treatment with intravenous tissue plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2888%2980073-8

7 January 2021

Acute pulmonary embolism. II. Clinical

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2888%2980073-8

7 January 2021

Streptokinase Therapy in Acute Major Pulmonary Embolism: Effectiveness and Problems

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2888%2980073-8

7 January 2021

Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2888%2980073-8

7 January 2021

Intravenous urokinase in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2888%2980073-8

7 January 2021

Rapid lysis of coronary artery thrombi with anisoylated plasminogen: streptokinase activator complex. Treatment by bolus intravenous injection

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2888%2980073-8

7 January 2021

Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase (pro-urokinase). A study in vitro and in two animal species

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2888%2980073-8

7 January 2021

Coronary thrombolysis with recombinant single-chain urokinase-type plasminogen activator in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2888%2980073-8

7 January 2021

Coronary arterial thrombolysis with low-dose synergistic combinations of recombinant tissue-type plasminogen activator (rt-PA) and recombinant single-chain urokinase-type plasminogen activator (rscu-PA) for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2888%2980073-8

7 January 2021

Coronary thrombolysis in patients with acute myocardial infarction by intravenous infusion of synergic thrombolytic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2888%2980073-8

7 January 2021

10.1016/S0196-0644(88)80073-8

Identifiers

DOI

1 reference

13 September 2017

1 reference